Roberto Piva
University of Turin(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Ubiquitin and proteasome pathways, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research, T-cell and Retrovirus Studies
Most-Cited Works
- → The anaplastic lymphoma kinase in the pathogenesis of cancer(2007)870 cited
- → Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma(2015)435 cited
- → Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death(2002)390 cited
- → Exercise training intervention after coronary angioplasty: the ETICA trial(2001)347 cited
- → CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib(2007)252 cited
- → NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors(2003)247 cited
- →